PHS
ROIV icon

PFM Health Sciences’s Roivant Sciences ROIV Stock Holding History

PFM Health Sciences’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.48M Buy
268,008
+60,562
+29% +$1.79M 0.81% 47
2026
Q1 		$5.75M Buy
+207,446
New +$5.33M 0.52% 58
2024
Q1 		– Sell
-1,215,033
Closed -$13.6M – 89
2023
Q4 		$13.6M Hold
1,215,033
– – 0.82% 41
2023
Q3 		$14.2M Buy
1,215,033
+830,042
+216% +$9.38M 0.67% 47
2023
Q2 		$3.88M Buy
+384,991
New +$3.44M 0.15% 70

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PFM Health Sciences's ROIV Position: Q2 2026 in Review

PFM Health Sciences increased its Roivant Sciences (ROIV) stake by 29% in Q2 2026, buying an estimated $1.79M and bringing the position to 268,008 shares worth $9.48M. The position accounts for 0.81% of the portfolio, ranked #47.

PFM Health Sciences first reported a position in ROIV in Q2 2023 and has held it in 5 quarters since. The position peaked at $14.2M in Q3 2023. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • PFM Health Sciences held 268,008 shares of Roivant Sciences worth $9.48M as of Q2 2026.
  • PFM Health Sciences bought 60,562 Roivant Sciences shares in Q2 2026, an estimated $1.79M.
  • Roivant Sciences made up 0.81% of PFM Health Sciences's portfolio in Q2 2026, its #47 holding.
  • PFM Health Sciences first reported a position in Roivant Sciences in Q2 2023 and has held it in 5 quarters since.
  • PFM Health Sciences's Roivant Sciences position peaked at $14.2M in Q3 2023.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.